High prevalence of erectile dysfunction in men with hyperthyroidism: a meta-analysis.


Journal

BMC endocrine disorders
ISSN: 1472-6823
Titre abrégé: BMC Endocr Disord
Pays: England
ID NLM: 101088676

Informations de publication

Date de publication:
30 Apr 2024
Historique:
received: 04 02 2023
accepted: 18 04 2024
medline: 1 5 2024
pubmed: 1 5 2024
entrez: 30 4 2024
Statut: epublish

Résumé

The objective of this study was to evaluate the association between hyperthyroidism and the risk of developing erectile dysfunction (ED). A comprehensive search of multiple databases, including PubMed, Embase, Cochrane, and Web of Science, was conducted to identify relevant studies investigating the relationship between hyperthyroidism and ED in men. The quality of the included studies was assessed using the Newcastle‒Ottawa Quality Rating Scale, and a meta-analysis was performed using Stata 16.0 and RevMan 5.3 software. A total of four papers encompassing 25,519 study subjects were included in the analysis. Among these, 6,429 individuals had hyperthyroidism, while 19,090 served as controls. The overall prevalence of ED in patients with hyperthyroidism was determined to be 31.1% (95% CI 0.06-0.56). In patients with uncomplicated hyperthyroidism, the incidence of ED was 21.9% (95% CI 0.05-0.38). The combined odds ratio (OR) for the four studies was 1.73 (OR: 1.73; 95% CI [1.46-2.04]; p < .00001). Our findings demonstrate a higher incidence of ED in patients with hyperthyroidism. These results provide valuable information for healthcare professionals and can facilitate discussions surrounding appropriate treatment options for ED in patients with hyperthyroidism.

Identifiants

pubmed: 38689308
doi: 10.1186/s12902-024-01585-6
pii: 10.1186/s12902-024-01585-6
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

58

Subventions

Organisme : Scientific Research Foundation of Hunan Provincial Education Department
ID : 21B0058
Organisme : Changsha Natural Science Foundation
ID : kq2202031
Organisme : Natural Science Foundation of Hunan Province
ID : NO. 2023JJ40068
Organisme : Natural Science Foundation of Hunan Province
ID : 2022JJ30628
Organisme : Hunan Province Assisted Reproduction and Regenerative Medicine Clinical Demonstration Center Funded Project
ID : 2020SK4019
Organisme : Hunan Province Assisted Reproduction and Regenerative Medicine Clinical Demonstration Center Funded Project
ID : 2020SK4019
Organisme : Hunan Provincial Health Commission Fund
ID : W20243010
Organisme : Clinical Medical Technology Demonstration Base for Genetic Research of Fetal Congenital Heart Disease in Hunan Province
ID : 2021SK4036
Organisme : Clinical Medical Technology Demonstration Base for Genetic Research of Fetal Congenital Heart Disease in Hunan Province
ID : 2021SK4036

Informations de copyright

© 2024. The Author(s).

Références

Shea BJ, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol. 2009;62(10):1013–20.
pubmed: 19230606 doi: 10.1016/j.jclinepi.2008.10.009
Cumpston M, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10(10):ED000142.
pubmed: 31643080
Kouidrat Y, et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med. 2017;34(9):1185–92.
pubmed: 28722225 doi: 10.1111/dme.13403
Taylor PN, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301–16.
pubmed: 29569622 doi: 10.1038/nrendo.2018.18
Bode H, et al. Hyperthyroidism and clinical depression: a systematic review and meta-analysis. Transl Psychiatry. 2022;12(1):362.
pubmed: 36064836 pmcid: 9445086 doi: 10.1038/s41398-022-02121-7
Lee SY, Pearce EN. Hyperthyroidism: A Review. JAMA. 2023;330(15):1472–83.
pubmed: 37847271 pmcid: 10873132 doi: 10.1001/jama.2023.19052
Nexo MA, et al. Exploring the experiences of people with hypo- and hyperthyroidism. Qual Health Res. 2015;25(7):945–53.
pubmed: 25294349 doi: 10.1177/1049732314554093
Cihan A, Esen AA. Systematic review and meta-analysis for the value of thyroid disorder screening in men with ejaculatory dysfunction. Int J Clin Pract. 2021;75(10): e14419.
pubmed: 34047440 doi: 10.1111/ijcp.14419
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.
pubmed: 20652370 doi: 10.1007/s10654-010-9491-z
Krassas GE, et al. Erectile dysfunction in patients with hyper- and hypothyroidism: how common and should we treat? J Clin Endocrinol Metab. 2008;93(5):1815–9.
pubmed: 18270255 doi: 10.1210/jc.2007-2259
Keller J, Chen YK, Lin HC. Hyperthyroidism and erectile dysfunction: a population-based case-control study. Int J Impot Res. 2012;24(6):242–6.
pubmed: 22717764 doi: 10.1038/ijir.2012.24
Carani C, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab. 2005;90(12):6472–9.
pubmed: 16204360 doi: 10.1210/jc.2005-1135
Veronelli A, et al. Prevalence of erectile dysfunction in thyroid disorders: comparison with control subjects and with obese and diabetic patients. Int J Impot Res. 2006;18(1):111–4.
pubmed: 16079903 doi: 10.1038/sj.ijir.3901364
Patel N, Kashanian JA. Thyroid Dysfunction and Male Reproductive Physiology. Semin Reprod Med. 2016;34(6):356–60.
pubmed: 27741548 doi: 10.1055/s-0036-1593491
Shen M, et al. Is There an Association Between Hypothyroidism and Sexual Dysfunction: A Systematic Review and Cumulative Analysis. Sex Med. 2021;9(3): 100345.
pubmed: 34087533 pmcid: 8240328 doi: 10.1016/j.esxm.2021.100345
Kalka D, et al. Diagnosis of hypogonadism in patients treated with low energy shock wave therapy for erectile dysfunction: a narrative review. Transl Androl Urol. 2020;9(6):2786–96.
pubmed: 33457250 pmcid: 7807342 doi: 10.21037/tau-20-796
Cihan A, Esen AA. The impact of hyperthyroidism on sexual functions in men and women: a systematic review and meta-analysis. Int J Impot Res. 2023;1–9.
Kessler A, et al. The global prevalence of erectile dysfunction: a review. BJU Int. 2019;124(4):587–99.
pubmed: 31267639 doi: 10.1111/bju.14813
Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84(1):50–6.
pubmed: 10444124 doi: 10.1046/j.1464-410x.1999.00142.x
Salonia A, et al. Is erectile dysfunction a reliable proxy of general male health status? The case for the International Index of Erectile Function-Erectile Function domain. J Sex Med. 2012;9(10):2708–15.
pubmed: 22897643 doi: 10.1111/j.1743-6109.2012.02869.x
Gandaglia G, et al. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol. 2014;65(5):968–78.
pubmed: 24011423 doi: 10.1016/j.eururo.2013.08.023
Besiroglu H, Otunctemur A, Ozbek E. The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies. J Sex Med. 2015;12(6):1309–18.
pubmed: 25872648 doi: 10.1111/jsm.12885
Sansone A, et al. Serum Homocysteine Levels in Men with and without Erectile Dysfunction: A Systematic Review and Meta-Analysis. Int J Endocrinol. 2018;2018:7424792.
pubmed: 30158975 pmcid: 6109500 doi: 10.1155/2018/7424792
Lin WY, et al. Atrial fibrillation is associated with increased risk of erectile dysfunction: A nationwide population-based cohort study. Int J Cardiol. 2015;190:106–10.
pubmed: 25918058 doi: 10.1016/j.ijcard.2015.04.108
Corona G, et al. Endocrinologic Control of Men’s Sexual Desire and Arousal/Erection. J Sex Med. 2016;13(3):317–37.
pubmed: 26944463 doi: 10.1016/j.jsxm.2016.01.007
Caretta N, et al. Hypovitaminosis D is associated with erectile dysfunction in type 2 diabetes. Endocrine. 2016;53(3):831–8.
pubmed: 26758995 doi: 10.1007/s12020-015-0851-z
Luo L, et al. Association between chronic obstructive pulmonary disease and risk of erectile dysfunction: a systematic review and meta-analysis. Int J Impot Res. 2020;32(2):159–66.
pubmed: 31263249 doi: 10.1038/s41443-019-0165-4
Psarra AM, Sekeris CE. Steroid and thyroid hormone receptors in mitochondria. IUBMB Life. 2008;60(4):210–23.
pubmed: 18344181 doi: 10.1002/iub.37
Carosa E, Lenzi A, Jannini EA. Thyroid hormone receptors and ligands, tissue distribution and sexual behavior. Mol Cell Endocrinol. 2018;467:49–59.
pubmed: 29175529 doi: 10.1016/j.mce.2017.11.006
Silva JF, Ocarino NM, Serakides R. Thyroid hormones and female reproduction. Biol Reprod. 2018;99(5):907–21.
pubmed: 29767691
Selva DM, Hammond GL. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4alpha. J Mol Endocrinol. 2009;43(1):19–27.
pubmed: 19336534 doi: 10.1677/JME-09-0025
Gabrielson AT, Sartor RA, Hellstrom WJG. The Impact of Thyroid Disease on Sexual Dysfunction in Men and Women. Sex Med Rev. 2019;7(1):57–70.
pubmed: 30057137 doi: 10.1016/j.sxmr.2018.05.002
Seftel AD, Sun P, Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol. 2004;171(6 Pt 1):2341–5.
pubmed: 15126817 doi: 10.1097/01.ju.0000125198.32936.38
Wang X, et al. High Prevalence of Erectile Dysfunction in Diabetic Men With Depressive Symptoms: A Meta-Analysis. J Sex Med. 2018;15(7):935–41.
pubmed: 29960629 doi: 10.1016/j.jsxm.2018.05.007
Isidori AM, et al. A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol. 2014;65(1):99–112.
pubmed: 24050791 doi: 10.1016/j.eururo.2013.08.048
Maggi M, et al. Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA). J Sex Med. 2013;10(3):661–77.
pubmed: 22524444 doi: 10.1111/j.1743-6109.2012.02735.x
Yuan J, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902–12.
pubmed: 23395275 doi: 10.1016/j.eururo.2013.01.012
Anaissie J, Hellstrom WJ. Clinical use of alprostadil topical cream in patients with erectile dysfunction: a review. Res Rep Urol. 2016;8:123–31.
pubmed: 27536559 pmcid: 4977016
Capogrosso P, et al. Low-Intensity Shock Wave Therapy in Sexual Medicine-Clinical Recommendations from the European Society of Sexual Medicine (ESSM). J Sex Med. 2019;16(10):1490–505.
pubmed: 31447380 doi: 10.1016/j.jsxm.2019.07.016
Levine LA, Dimitriou RJ. Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am. 2001;28(2):335–41 ix-x.
pubmed: 11402585 doi: 10.1016/S0094-0143(05)70142-7
Porst H, et al. SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med. 2013;10(1):130–71.
pubmed: 23343170 doi: 10.1111/jsm.12023
Salonia A, et al. Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function. Eur Urol. 2012;62(2):273–86.
pubmed: 22575910 doi: 10.1016/j.eururo.2012.04.047
Fruhauf S, et al. Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis. Arch Sex Behav. 2013;42(6):915–33.
pubmed: 23559141 doi: 10.1007/s10508-012-0062-0
Gupta BP, et al. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011;171(20):1797–803.
pubmed: 21911624 doi: 10.1001/archinternmed.2011.440

Auteurs

Xiaowen Liu (X)

Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care, Hunan Normal University, Changsha, China. 124821877@qq.com.

Yanling Wang (Y)

Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care, Hunan Normal University, Changsha, China.

Li Ma (L)

Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care, Hunan Normal University, Changsha, China.

Danhui Wang (D)

Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care, Hunan Normal University, Changsha, China.

Zhihong Peng (Z)

College of Health Science and Engineering, Hubei University, Wuhan, China.

Zenghui Mao (Z)

Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care, Hunan Normal University, Changsha, China. 519286369@qq.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH